Asha Paireddy

712 total citations
11 papers, 460 citations indexed

About

Asha Paireddy is a scholar working on Urology, Surgery and Rheumatology. According to data from OpenAlex, Asha Paireddy has authored 11 papers receiving a total of 460 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Urology, 6 papers in Surgery and 6 papers in Rheumatology. Recurrent topics in Asha Paireddy's work include Urinary Bladder and Prostate Research (10 papers), Pelvic floor disorders treatments (6 papers) and Urinary Tract Infections Management (4 papers). Asha Paireddy is often cited by papers focused on Urinary Bladder and Prostate Research (10 papers), Pelvic floor disorders treatments (6 papers) and Urinary Tract Infections Management (4 papers). Asha Paireddy collaborates with scholars based in United States, United Kingdom and Netherlands. Asha Paireddy's co-authors include Arwin Ridder, Paul Abrams, Rob van Maanen, Donald Newgreen, David Staskin, Con Kelleher, Tomasz Rechberger, Richard Kay, Matthias Stoelzel and Sender Herschorn and has published in prestigious journals such as The Journal of Urology, European Urology and British Journal of Urology.

In The Last Decade

Asha Paireddy

11 papers receiving 451 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Asha Paireddy United States 8 425 339 269 66 40 11 460
M. Wooning Netherlands 7 462 1.1× 340 1.0× 258 1.0× 80 1.2× 54 1.4× 8 499
Budiwan Sumarsono South Korea 10 352 0.8× 299 0.9× 189 0.7× 39 0.6× 29 0.7× 22 402
Gerd Mürtz Germany 13 535 1.3× 444 1.3× 275 1.0× 40 0.6× 13 0.3× 22 578
Joseph Wang United States 6 421 1.0× 335 1.0× 224 0.8× 102 1.5× 12 0.3× 8 467
G. Primus Austria 10 251 0.6× 224 0.7× 143 0.5× 71 1.1× 15 0.4× 25 343
Sara Y. Gao United States 6 294 0.7× 176 0.5× 134 0.5× 57 0.9× 15 0.4× 11 350
Hong Jin Suh South Korea 8 423 1.0× 320 0.9× 157 0.6× 52 0.8× 50 1.3× 20 487
Jon D. Morrow United States 11 483 1.1× 441 1.3× 254 0.9× 110 1.7× 15 0.4× 17 524
Hans-Theo Forst Germany 2 342 0.8× 264 0.8× 171 0.6× 76 1.2× 11 0.3× 4 355
Sheila O. Brown United States 4 243 0.6× 169 0.5× 77 0.3× 24 0.4× 19 0.5× 6 291

Countries citing papers authored by Asha Paireddy

Since Specialization
Citations

This map shows the geographic impact of Asha Paireddy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asha Paireddy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asha Paireddy more than expected).

Fields of papers citing papers by Asha Paireddy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Asha Paireddy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asha Paireddy. The network helps show where Asha Paireddy may publish in the future.

Co-authorship network of co-authors of Asha Paireddy

This figure shows the co-authorship network connecting the top 25 collaborators of Asha Paireddy. A scholar is included among the top collaborators of Asha Paireddy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Asha Paireddy. Asha Paireddy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
White, William B., Christopher R. Chapple, Christian Gratzke, et al.. (2018). Cardiovascular Safety of the β3‐Adrenoceptor Agonist Mirabegron and the Antimuscarinic Agent Solifenacin in the SYNERGY Trial. The Journal of Clinical Pharmacology. 58(8). 1084–1091. 17 indexed citations
2.
Gratzke, Christian, Rob van Maanen, Christopher R. Chapple, et al.. (2018). Long-term Safety and Efficacy of Mirabegron and Solifenacin in Combination Compared with Monotherapy in Patients with Overactive Bladder: A Randomised, Multicentre Phase 3 Study (SYNERGY II). European Urology. 74(4). 501–509. 67 indexed citations
3.
Weber, Michael A., Christopher R. Chapple, Christian Gratzke, et al.. (2018). A strategy utilizing ambulatory monitoring and home and clinic blood pressure measurements to optimize the safety evaluation of noncardiovascular drugs with potential for hemodynamic effects. Blood Pressure Monitoring. 23(3). 153–163. 10 indexed citations
4.
Gratzke, Christian, Rob van Maanen, Christopher R. Chapple, et al.. (2017). PNFLBA-09 LONG-TERM COMBINATION TREATMENT WITH SOLIFENACIN AND MIRABEGRON IS EFFECTIVE AND WELL TOLERATED IN PATIENTS WITH OVERACTIVE BLADDER. The Journal of Urology. 197(4S). 1 indexed citations
5.
Herschorn, Sender, Christopher R. Chapple, Paul Abrams, et al.. (2017). Efficacy and safety of combinations of mirabegron and solifenacin compared with monotherapy and placebo in patients with overactive bladder ( SYNERGY study). British Journal of Urology. 120(4). 562–575. 108 indexed citations
6.
Robinson, Dudley, Con Kelleher, David Staskin, et al.. (2017). Patient‐reported outcomes from SYNERGY, a randomized, double‐blind, multicenter study evaluating combinations of mirabegron and solifenacin compared with monotherapy and placebo in OAB patients. Neurourology and Urodynamics. 37(1). 394–406. 24 indexed citations
7.
8.
Abrams, Paul, Jean Paty, Reynaldo Martina, et al.. (2015). Electronic bladder diaries of differing duration versus a paper diary for data collection in overactive bladder. Neurourology and Urodynamics. 35(6). 743–749. 22 indexed citations
9.
Abrams, Paul G., C. Kelleher, David Staskin, et al.. (2014). 574 Cardiovascular safety of combination treatment with mirabegron and solifenacin in patients with overactive bladder in a randomised, double-blind, dose-ranging, Phase II study (Symphony). European Urology Supplements. 13(1). e574–e574a. 5 indexed citations
10.
11.
Abrams, Paul, Con Kelleher, David Staskin, et al.. (2013). 1958 COMBINATION TREATMENT WITH MIRABEGRON AND SOLIFENACIN IN PATIENTS WITH OVERACTIVE BLADDER (OAB) - EFFICACY RESULTS FROM A PHASE 2 STUDY (SYMPHONY). The Journal of Urology. 189(4S). 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Wooning Breakdown of academic impact, for papers by Budiwan Sumarsono Breakdown of academic impact, for papers by Gerd Mürtz Breakdown of academic impact, for papers by Joseph Wang Breakdown of academic impact, for papers by G. Primus Breakdown of academic impact, for papers by Sara Y. Gao Breakdown of academic impact, for papers by Hong Jin Suh Breakdown of academic impact, for papers by Jon D. Morrow Breakdown of academic impact, for papers by Hans-Theo Forst Breakdown of academic impact, for papers by Sheila O. Brown
Rankless by CCL
2026